Literature DB >> 9015170

Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus.

M S Bhansali1, H Fujita, T Kakegawa, H Yamana, T Ono, S Hikita, Y Toh, T Fujii, U Tou, K Shirouzu.   

Abstract

Factors responsible for recurrence of esophageal cancer were investigated in 90 patients who underwent extended radical esophagectomy with three-field dissection for a squamous cell carcinoma in the thoracic esophagus. The initial tumor recurrence was grouped as either locoregional (site of the primary tumor, anastomotic site, or lymph nodes) or as distant (distant organs, pleura, or peritoneum). Nineteen patients (21%) developed a locoregional recurrence, and 19 (21%) developed a distant recurrence. One (1%) developed both recurrences simultaneously and was classified as a distant recurrence. The locoregional recurrence was correlated with the stage factors, particularly the number of metastasis-positive nodes. For the distant recurrence, vascular invasion was found to have been the most important prognostic factor. Our findings suggested that locoregional recurrence was due to tumor progress related to the extent of lymph node metastasis, whereas distant recurrence was due to the oncologic behavior of the tumor. Locoregional recurrence in patients with limited disease may be reduced by extended radical esophagectomy with three-field dissection. Distant recurrence cannot be controlled by surgery. Adopted postoperative adjuvant therapies showed no effect on recurrence.

Entities:  

Mesh:

Year:  1997        PMID: 9015170     DOI: 10.1007/s002689900228

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  47 in total

1.  A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy.

Authors:  X Ding; J Zhang; B Li; Z Wang; W Huang; T Zhou; Y Wei; H Li
Journal:  Br J Radiol       Date:  2012-06-14       Impact factor: 3.039

Review 2.  Multimodal treatment for resectable esophageal cancer.

Authors:  Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Shuji Takiguchi; Kiyokazu Nakajima; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-07-14

3.  Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection.

Authors:  Hideaki Shimada; Shin-ichi Okazumi; Hisahiro Matsubara; Yoshihiro Nabeya; Tooru Shiratori; Takanori Shimizu; Kiyohiko Shuto; Hideki Hayashi; Takenori Ochiai
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

4.  Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection.

Authors:  Po-Kuei Hsu; Bing-Yen Wang; Chien-Sheng Huang; Yu-Chung Wu; Wen-Hu Hsu
Journal:  J Gastrointest Surg       Date:  2011-02-15       Impact factor: 3.452

5.  BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.

Authors:  Yu Tian; Cong Wang; Ming Lu
Journal:  Surg Today       Date:  2018-09-04       Impact factor: 2.549

6.  Patterns and time of recurrence after complete resection of esophageal cancer.

Authors:  Masahiko Sugiyama; Masaru Morita; Rintaro Yoshida; Koji Ando; Akinori Egashira; Ohga Takefumi; Hiroshi Saeki; Eiji Oki; Yoshihiro Kakeji; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-02-28       Impact factor: 2.549

7.  Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.

Authors:  Punit Sharma; Sachin Jain; Sellam Karunanithi; Sujoy Pal; Pramod Kumar Julka; Sanjay Thulkar; Arun Malhotra; Chandrasekhar Bal; Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236

8.  Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma.

Authors:  Yuichiro Doki; Osamu Ishikawa; Ko Takachi; Isao Miyashiro; Yo Sasaki; Hiroaki Ohigashi; Kohei Murata; Terumasa Yamada; Shingo Noura; Hidetoshi Eguchi; Toshiyuki Kabuto; Shingi Imaoka
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

9.  Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases.

Authors:  Yaping Xu; Qixun Chen; Xinmin Yu; Ximing Zhou; Xiao Zheng; Weimin Mao
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

10.  Prediction of hematogenous recurrence in patients with esophageal carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Katsuhiko Tsukada; Hiroyuki Kuwano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.